Poseida Therapeutics Inc (PSTX) Directors and Executive Officers - CSIMarket
CSIMarket
 
Poseida Therapeutics Inc   (NASDAQ: PSTX)

Poseida Therapeutics Inc

Officers & Directors


Mark J. Gergen
Executive Chairman and Director

Luke Corning
Director

Kristin Yarema, Ph.D.
Chief Executive Officer (Principal Executive Officer)
President and Director

Marcea B. Lloyd
Director

Charles M. Baum
Director

Johanna M. Mylet
Chief Financial Officer (Principal Financial and Accounting Officer)

Cynthia Collins
Director

Rafael Amado
Director

John P. Schmid
Director ,

Poseida Therapeutics Inc currently has 330 employees.

  News about Poseida Therapeutics Inc Key Personnel

Poseida Therapeutics Employs Dr. Syed Rizvi, M.D., as Chief Medical Officer, Navigating Share Value Decline Amid Promising Cell and Gene Therapy Advancements.

Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer; Shares Fall by 3.42% in a Challenging Market
SAN DIEGO, March 25, 2024 - Poseida Therapeutics, Inc. (Nasdaq: PSTX), a renowned clinical-stage cell and gene therapy company dedicated to revolutionizing treatments for cancer and rare diseases, has made a significant addition to its leadership team. Today, the company proudly announced the appointment of accomplished medical professional Syed Rizvi, M.D., as its Chief Medical Officer. While this announcement comes with great expectations for the future, Poseida Therapeutics also faces the challenge of a recent decline in share value.
Dr. Rizvi brings a wealth of expertise and expe...






PSTX Management Effectiveness PSTX Revenue per Employee PSTX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.